PPP1R1B and Huntington disease: Because DARPP-32 expression in the striatum is specific to MSNs, the combination of biochemical and histologic findings in these studies suggests NV-5297 treatment in HD mice is associated with increased MSN neurite density and is thus protective in the setting of mHTT expression.